Aldeyra Therapeutics Provides Regulatory Update on ADX-2191

LEXINGTON, Mass.--(BUSINESS WIRE)--Jun. 21, 2023-- (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced receipt of a Complete...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news